DiaMedica Therapeutics
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $21,267,000.

Profit Margin

DiaMedica Therapeutics Inc. (NASDAQ:DMAC): Profit margin
2014 0 -4.81M
2015 0 -1.44M
2016 0 -2.22M
2017 0 -4.26M
2018 500K -5.73M -1146.8%
2019 0 -10.64M
2020 0 -12.29M
2021 0 -13.59M
2022 0 -13.67M
2023 0 -19.38M

DMAC Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
00000500K0000
Cost of revenue
30K25K24K21K21K04K2.21K4.45K0
Gross profit
-30K-25K-24K-21K-21K500K-4K-2.21K-4.45K0
Operating exp.
Research and development
13.11M7.83M8.76M8.31M7.9M4.52M3.20M1.76M886.07K3.71M
Selling and marketing
0000000000
Total operating expenses
21.26M14.00M13.64M12.49M10.73M6.04M4.27M2.48M1.30M4.83M
Operating income
-21.26M-14.00M-13.64M-12.69M-11.59M-6.76M-4.51M-2.48M-1.30M-4.83M
Other income (expenses), net
1.92M353K82K434K975K-107K259K331.56K-104.38K-185.41K
Income before tax
-19.33M-13.64M-13.56M-12.26M-10.61M-5.65M-4.26M-2.20M-1.43M-4.77M
Income tax expense
43K28K28K27K31K80K-9K22.31K12.45K42.28K
Net income
-19.38M-13.67M-13.59M-12.29M-10.64M-5.73M-4.26M-2.22M-1.44M-4.81M
Earnings per share
Basic EPS
-0.6-0.52-0.65-0.78-0.89-0.74-0.72-0.47-0.4-1.55
Diluted EPS
-0.6-0.52-0.65-0.78-0.89-0.74-0.72-0.47-0.4-1.55
Data sourceData sourceData sourceData sourceData sourceData source